United States - English - NLM (National Library of Medicine)

church & dwight co., inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - benzocaine - oral pain reliever menthol - oral pain reliever zinc chloride - oral astringent use • or temporary relief of oral pain due to minor irritation or injury of the mouth and gums do not use • more than directed • for more than 7 days unless directed by a physician or healthcare provider stop use and ask a physician if • swelling, rash or fever develops • irritation, pain or redness persists or worsens • symptoms do not improve in 7 days if allergic reaction occurs.

United States - English - NLM (National Library of Medicine)

church & dwight co., inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - benzocaine - oral pain reliever menthol - oral pain reliever zinc chloride - oral astringent use • for the temporary relief of oral pain due to minor irritation or injury of the mouth and gums do not use • more than directed • for more than 7 days unless directed by a physician or healthcare provider stop use and ask a physician if • swelling, rash or fever develops • irritation, pain or redness persists or worsens • symptoms do not improve in 7 days • allergic reaction occurs

United States - English - NLM (National Library of Medicine)

meijer distribution inc - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5) - purpose oral pain reliever oral pain reliever astringent use - for the temporary relief of oral pain due to minor irritation or injury of the mouth and gums

Philippines - English - FDA (Food And Drug Administration)

time machine cosmetiques, inc. - clindamycin (as phosphate) - astringent solution - 10mg/0.1mg per ml

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated clostridium perfringens b and e , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml (dose) contains: clostridium perfringens (type b, c, and d) b toxoid .................... > 10 iu/ml clostridium perfringens (type b, c, and d) e toxoid............. >3.5 iu/ml clostridium novyi (type b) a toxoid......... > 2.5 iu/ml clostridium septicum a toxoid ............. clostridium chauvoei ............ ........... 100 % protection clostridium tetani toxoid........... > 2.5 iu/ml

Philippines - English - FDA (Food And Drug Administration)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated clostridium perfringens b and € , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml[dose) contains: clostridium perfringens (type b, c and d) b toxoid ->10 iu c. perfringens (type b, c and d) e toxoid-5iu clostridium novyi (type b) e toxoid->5 iu clostridium septicum a toxoid-->5 iu clostridium chauvoei- 100% protection clostridium tetani-->5 iu

United States - English - NLM (National Library of Medicine)

first aid research corp. - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - external analgesic / anti-itch skin protectant / anorectal astringent a moisture barrier that prevents and helps heal skin irritation from: • urine • diarrhea • perspiration • fistula damage • feeding tube site leakage • wound drainage (peri-wound skin) • minor burns • cuts • scrapes • itching

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - escherichia coli fimbrial adhesins , e. coli lt enterotoxoid , clostridium perfringens b-toxoid , c. novyi type b a-toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: e. coli (f4ab fimbrial adhesin) e. coli (f4ac fimbrial adhesin) e. coli (f5 fimbrial adhesin) e. coli (f6 fimbrial adhesin) lt enterotoxoid of e.coli b-toxoid clostridium perfringens, type c á-toxoid clostridium novyi $5% er * »78% er70 59% er30 80% er25 5% er 70 5% ers >50% er 120

Philippines - English - FDA (Food And Drug Administration)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated escherichia coli fimbrial adhesin (f4ab, f4ac, f5 and f6) , heat labile (lt) enterotoxoid , clotridium perfringens (type c) b toxoid , clostridium novyi (type b) a toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response.

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens b-toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum)